BUY Max Financial Services Limited — Bernstein
byBernsteinHorizon: 1 year17 Sept 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
8 midcap stocks with over 100% profit growth in Q2FY27
NewsEt-Markets·30 Oct · 1w ago
Max Financial Services reports massive profit growth of Rs 100 crore in Q2 FY26
NewsEt-Markets·28 Oct · 1w ago
Max Financial Services reported H1 FY27 consolidated revenue growth of 16% and a 137% increase in consolidated PAT to ₹219 crores. Subsidiary Axis Max Life saw 21% growth in Value of New Business.
NSE · Press Release·27 Oct · 1w ago
Max Financial Services reported strong H1 FY27 results, with consolidated revenue growing 16% YoY and PAT increasing 137% to ₹219 crores. Subsidiary Axis Max Life saw a 21% increase in VNB.
BSE · Company Update·27 Oct · 1w ago
1 advisor has an active short-term BUY call on this stock
Advisor consensus · adjacent horizon·14 Oct · 3w ago
Long-term trend bearish — 200-day average falling over the past quarter
Technicals · trend·6 Nov · yesterday
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Max Financial Services
- BUY — Ansh Jogendra Bhilwar28 Oct 2026 · Same day · target ₹1,265 · SL hit
- BUY — Ansh Jogendra Bhilwar14 Oct 2026 · ~3 months · target ₹1,460 · Active
- BUY — Jefferies India28 Sept 2026 · ~1 year · target ₹2,050 · Active
- BUY — Kunal Parar, Choice Broking25 Sept 2026 · ~2 weeks · target ₹1,550 · SL hit
- SELL — Ashish Kyal, Waves Strategy Advisors25 Sept 2026 · ~2 weeks · target ₹1,350 · Target hit
More from Bernstein
- BUY Titan Company6 Nov 2026 · ~1 year · target ₹5,400 · Active
- BUY Pfizer5 Nov 2026 · ~1 year · target ₹4,424 · Active
- SELL BSE5 Nov 2026 · ~1 year · target ₹3,180 · Active
- BUY GlaxoSmithKline Pharmaceuticals5 Nov 2026 · ~1 year · target ₹3,430 · Active
- BUY Devyani International3 Nov 2026 · ~1 year · target ₹160 · Active

